CN110613784A - 一种预防和治疗乳腺增生性疾病的纯天然中药方剂 - Google Patents
一种预防和治疗乳腺增生性疾病的纯天然中药方剂 Download PDFInfo
- Publication number
- CN110613784A CN110613784A CN201910977244.8A CN201910977244A CN110613784A CN 110613784 A CN110613784 A CN 110613784A CN 201910977244 A CN201910977244 A CN 201910977244A CN 110613784 A CN110613784 A CN 110613784A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- chinese medicine
- hyperplasia
- mammary glands
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 65
- 206010020718 hyperplasia Diseases 0.000 title claims abstract description 45
- 210000005075 mammary gland Anatomy 0.000 title claims abstract description 43
- 239000000284 extract Substances 0.000 claims abstract description 25
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 21
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 12
- 244000183278 Nephelium litchi Species 0.000 claims abstract description 11
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 11
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 10
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 10
- 241000237502 Ostreidae Species 0.000 claims abstract description 10
- 235000020636 oyster Nutrition 0.000 claims abstract description 10
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 9
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 9
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 9
- 235000015742 Nephelium litchi Nutrition 0.000 claims abstract description 9
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000008113 selfheal Nutrition 0.000 claims abstract description 7
- 241000218206 Ranunculus Species 0.000 claims abstract description 5
- 239000002552 dosage form Substances 0.000 claims abstract description 4
- 229940126680 traditional chinese medicines Drugs 0.000 claims abstract description 4
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 3
- 239000002245 particle Substances 0.000 claims abstract description 3
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 244000192528 Chrysanthemum parthenium Species 0.000 claims abstract 2
- 244000088415 Raphanus sativus Species 0.000 claims abstract 2
- 239000007788 liquid Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 55
- 239000000203 mixture Substances 0.000 abstract description 7
- 238000009472 formulation Methods 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 20
- 230000036407 pain Effects 0.000 description 19
- 229940079593 drug Drugs 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 15
- 241000245665 Taraxacum Species 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 230000009471 action Effects 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 238000011160 research Methods 0.000 description 12
- 206010062717 Increased upper airway secretion Diseases 0.000 description 11
- 208000026435 phlegm Diseases 0.000 description 11
- 241000220259 Raphanus Species 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 9
- 241000207925 Leonurus Species 0.000 description 7
- 210000000481 breast Anatomy 0.000 description 7
- 230000001603 reducing effect Effects 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 241000915604 Scutellaria barbata Species 0.000 description 6
- 206010042674 Swelling Diseases 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 244000276331 Citrus maxima Species 0.000 description 4
- 235000001759 Citrus maxima Nutrition 0.000 description 4
- 244000075634 Cyperus rotundus Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 210000000941 bile Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 235000005272 common selfheal Nutrition 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 241001480043 Arthrodermataceae Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- MCTQNEBFZMBRSQ-GEEYTBSJSA-N Chrysoidine Chemical compound Cl.NC1=CC(N)=CC=C1\N=N\C1=CC=CC=C1 MCTQNEBFZMBRSQ-GEEYTBSJSA-N 0.000 description 3
- 244000150195 Cyperus longus Species 0.000 description 3
- 235000018109 Cyperus longus Nutrition 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 235000005010 Scirpus paludosus Nutrition 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000037304 dermatophytes Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 231100000167 toxic agent Toxicity 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010947 Coordination abnormal Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010040007 Sense of oppression Diseases 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 208000030270 breast disease Diseases 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 244000230030 foxtail bristlegrass Species 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 239000000399 hydroalcoholic extract Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000016290 incoordination Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- GXFZCDMWGMFGFL-KKXMJGKMSA-N (+)-Tubocurarine chloride hydrochloride Chemical compound [Cl-].[Cl-].C([C@H]1[N+](C)(C)CCC=2C=C(C(=C(OC3=CC=C(C=C3)C[C@H]3C=4C=C(C(=CC=4CC[NH+]3C)OC)O3)C=21)O)OC)C1=CC=C(O)C3=C1 GXFZCDMWGMFGFL-KKXMJGKMSA-N 0.000 description 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 1
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 206010006272 Breast mass Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 241001111317 Chondrodendron tomentosum Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 239000008709 Curare Substances 0.000 description 1
- 235000016854 Cyperus rotundus Nutrition 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 241001608711 Melo Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 244000084767 Potentilla indica Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 102000008063 Small Heat-Shock Proteins Human genes 0.000 description 1
- 108010088928 Small Heat-Shock Proteins Proteins 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000893963 Trichophyton concentricum Species 0.000 description 1
- 241001480046 Trichophyton schoenleinii Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- RPMNUQRUHXIGHK-PYXJVEIZSA-N apigenin 7-O-neohesperidoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 RPMNUQRUHXIGHK-PYXJVEIZSA-N 0.000 description 1
- 229930034861 apigenin-7-O-neohesperidoside Natural products 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 229940067866 dandelion extract Drugs 0.000 description 1
- 235000020691 dandelion extract Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000015355 drug-resistant tuberculosis Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000002095 exotoxin Substances 0.000 description 1
- 231100000776 exotoxin Toxicity 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016629 fibroma Diseases 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000019668 heartiness Nutrition 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000009671 multidrug-resistant tuberculosis Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- RPMNUQRUHXIGHK-SBDOOABHSA-N rhoifolin Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1cc(O)c2C(=O)C=C(c3ccc(O)cc3)Oc2c1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 RPMNUQRUHXIGHK-SBDOOABHSA-N 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000016160 smooth muscle contraction Effects 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 229960005559 sulforaphane Drugs 0.000 description 1
- 235000015487 sulforaphane Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- 239000001845 taraxacum officinale leaf extract Substances 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗和预防乳腺增生性疾病的纯天然中药方剂,其特征在于有下述重量配比的中药组成:蒲公英5‑30g,牡蛎5‑30g,橘核5‑30g,白芷5‑30g,山栀子5‑30g,半枝莲5‑30g,荔枝核5‑30g,益母草5‑30g,猫爪草5‑30g,夏枯草5‑30g,橘红5‑30g,香附5‑30g,莱菔子5‑30g,水煎浓缩提取物混合粉碎至100‑200目粒度后,制成中药制剂。所述的中药制剂为中药学上所述的任何一种剂型。以上中药的联合应用,协同发挥临床作用,对于预防和治疗乳腺增生性疾病具有非常良好的疗效,比使用单一的药物疗效确切。该方剂于2005年投入临床实验。患者普遍满意,适用于乳腺增生病患者。
Description
技术领域:本发明涉及预防和治疗乳腺增生性疾病的药物,特别是一种治疗和预防乳腺增生性疾病的纯天然中药方剂。
背景技术:乳腺增生症是乳腺增生是指乳腺上皮和纤维组织增生,乳腺组织导管和乳小叶在结构上的退行性病变及进行性结缔组织的生长,其发病原因主要是由于内分泌激素失调。乳腺增生症是女性最常见的乳房疾病,其发病率占乳腺疾病的首位。近些年来该病发病率呈逐年上升的趋势,年龄也越来越低龄化。据调查约有60%~70%的女性都有不同程度的乳腺增生,多见于25~45岁的女性。
乳腺增生是一种妇科常见的疾病。好发于20-40岁左右的青中年妇女,表现为乳房的不同部位单发或多发地生长一些肿块,质地柔软,边界不清,可活动,常伴有不同程度的疼痛。尤其在月经前、劳累后或是生气(中医称气郁)等情绪波动时,肿块增大,疼痛加重,而在月经后肿块明显缩小,疼痛减轻。疼痛一般是胀痛,很少有刺痛感。应该提醒的是,乳腺增生有转变为乳腺癌的可能,所以如果患乳腺有增生时间较长者则应去医院检查,以便及时诊断和治疗。
当前市场上用于乳腺增生的药物主要有乳宁颗粒、乳癖消等中成药,这些中成药针对性不强,效果差,或易复发,多为治疗妇科多种疾病甚或治疗肿瘤的药物,兼治乳腺增生,或者只针对乳腺增生病的某一症状或某一病理环节,且价格昂贵。
发明内容:本发明的有益效果在于,本发明的中药组合物,含有多种中药组分,具有养阴、疏肝理气、软坚散结、活血通络的功效,可加速乳块消散,具有疗效短、见效快、无毒副作用、不易复发,对乳腺增生治疗效果显著。
为了解决上述技术问题,本发明采用的技术方案如下:
一种预防和治疗乳腺增生的中药组合物,由以下各组分组成:
蒲公英、牡蛎、橘核、白芷、山栀子、半枝莲、荔枝核、益母草、猫爪草、夏枯草、橘红、香附、莱菔子。
本发明由以下重量份数的各组分组成:
蒲公英5-30g,牡蛎5-30g,橘核5-30g,白芷5-30g,山栀子5-30g,半枝莲5-30g,荔枝核5-30g,益母草5-30g,猫爪草5-30g,夏枯草5-30g,橘红5-30g,香附5-30g,莱菔子5-30g,.
在本发明的上述中药组合物中:
中药通过调节激素和受体水平、抗新生血管生成、抗氧化、改善血液黏稠度、调节免疫功能、诱导细胞凋亡、调控微量元素来达到治疗乳腺增生的作用。
蒲公英:
【性味归经】性寒,味苦、甘。归肝经、胃经。
【功效与作用】清热解毒,利尿散结。具有清热解毒、消痈散结、通乳、抗肿痛的功效
【临床应用】内服煎汤,捣汁或人散剂。治疗急性乳腺炎、淋巴腺炎、瘰疬、疔毒疮肿、急性结膜炎、感冒发热、急性扁桃体炎、急性支气管炎、胃炎、肝炎、胆囊炎、尿路感染。
【药理研究】具有抗病原微生物作用,抗肿瘤,抗胃溃疡,利胆及保肝,低浓度时直接兴奋离体蛙心,而高浓度时则呈抑制作用。能提高离体十二指肠的紧张性并加强其收缩力,临床认为有健胃和轻泻作用。注射液在试管内对金黄色葡萄球菌耐药菌株、溶血性链球菌有较强的杀菌作用,对肺炎双球菌、脑膜炎球菌、白喉杆菌、绿脓杆菌、变形杆菌、痢疾杆菌、伤寒杆菌及卡他球菌亦有一定的杀菌作用。毒性:小白鼠静脉注射蒲公英注射液的LDso为(58.88±7.94)克/千克,小鼠、兔亚急性毒性试验对肾脏可出现少量管型,肾小管上皮细胞浊肿缎带,煎剂给大鼠口服,吸收良好,尿中能保持一定的抗菌作用。
【配伍药方】①治乳痈初起:蒲公英30克,忍冬藤60克,生甘草6克。水二盅,煎一盅,食前服。(《洞天奥旨》英藤扬);
橘核:
【性味归经】性平,味苦。归肝经、肾经。
【功效与作用】理气,散结,止痛。
【临床应用】水煎服,或入丸、散。用治疝气疼痛,睾丸肿痛,乳痈乳癖。
【药理研究】1.解热,用橘核煎剂给实验性发热的家兔灌胃(10克/公斤体重),有一定的解热作用,但较安基比林缓慢。2.对平滑肌,用橘核煎剂及浸剂对家兔的肠肌和子宫均有兴奋作用。3.抑菌,在抑菌试验中,对结核杆菌中度敏感。4.镇痛,用橘核对小白鼠(当用10克/公斤剂量时)未见有直接的镇痛作用。
山栀子:
【性味归经】性寒,味苦。归心经、肺经、三焦经。
【功效与作用】泻火除烦、清热利尿、凉血解毒;外用消肿止痛。
【临床应用】煎服;或入丸、散。外用;适量,研末掺或调敷。用治温病热郁心胸,心烦、郁闷、躁扰不宁、睡眠不安;肝胆湿热郁结、黄疸、发热、小便短赤;血热妄行之吐血、衄血、尿血、跌打损伤、烫伤、烧伤等。肝火目赤、头痛、口舌生疮、疮疡肿毒、扭伤肿痛。
【药理研究】保护消化系统;泻下;降温;增加细胞中DNA和蛋白质合成;抗菌;抗炎;能增强胆汁的分泌而具有利胆、抑制血中胆红素形成的作用;能抑制中枢神经系统而具镇静、降压、抗惊厥、镇痛的作用;体外实验对多种致病菌有抑制作用。
半枝莲:
【性味归经】味辛、苦,性寒。归肺经、肝经、肾经。
【功效与作用】清热解毒、活血化瘀、利尿。属清热药下属中的清热解毒药。
【临床应用】,煎服;或入丸、散。外用鲜品适量,捣敷患处。用治晚期血吸虫病腹水、肝硬化腹水、毒蛇咬伤、疮疖痈肿。
【药理研究】抗癌,对急性粒细胞型白血病(NvIL)血细胞有轻度抑制作用。提高免疫系统功能,但大剂量注射可抑制小鼠胸腺指数;有抑菌作用;有较强的对抗由组胺引起的平滑肌收缩作用。有很好的解痉祛痰作用。具有利尿、兴奋呼吸及解蛇毒的作用。
荔枝核:
【性味归经】性温,味甘、微苦。归肝经、肾经。
【功效与作用】行气散结、祛寒止痛。属理气药。
【临床应用】煎服。《纲目》:行散滞气,妇人血气刺痛。用治腹痛、乳痛、经痛、睾丸肿痛。荔枝核1枚,锻存性,酒调服。治心痛及小肠气(《本草衍义》)。
【药理研究】具有降血糖、抑制乙肝抗原等、降肝糖原作用。抗肿瘤、抗血小板凝聚。
益母草:
【性味归经】性微寒,味苦、辛。归肝经、心经、膀胱经。
【功效与作用】活血调经、利尿消肿。
【临床应用】用治妇女血瘀的痛经、闭经、经行不畅、产后瘀阻腹痛;水肿、小便不利等。
【药理研究】具有兴奋子宫、增加冠状动脉流量、改善微循环、扩张外周血管及降低血压等作用,还有利尿及抑制皮肤真菌等作用。具有收缩子宫平滑肌的作用;能显著增加缺血性心肌冠脉流量及减慢心率;抗血小板聚集及抗血栓形成,增强机体细胞免疫功能,小剂量兴奋呼吸中枢,大剂量抑制;小剂量能使离体肠管紧张性弛缓,振幅扩大,大剂量则振幅变小,而频率增加;治疗缺血型初发期急性肾功能衰竭具有显著效果,可见尿量显著增加。对神经肌肉标本呈箭毒样作用。在试管内具有一定的抑制皮肤真菌作用。在较高浓度时能使血悬液发生溶血作用。
猫爪草:
【性味归经】性温,味甘、辛。归肝经、肺经。
【功效与作用】散结、解毒、消肿。
【临床应用】水煎服,外用捣敷或研末撒。用治瘰疬结核、肺结核、疔疮疖肿、龋齿疼痛。
【药理研究】1.抗肿瘤作用:猫爪草乙醇提取物体外在L929细胞结合肉瘤S180细胞的筛选模型中有诱生肿瘤坏死因子的作用,其有效成分为软脂酸。
2.抗结核作用猫爪草中的小毛茛内酯减少耐药结核患者周围血淋巴细胞内结核休眠菌小热休克蛋白基因的表达,激活休眠菌的同时增加周围血淋巴细胞内颗粒裂解肽mRNA的表达,增强机体细胞毒性淋巴细胞杀菌能力,达到抗耐药的作用。
【配伍药方】①治肺结核:猫爪草60克。水煎,分2次服。(《河南中草药手册》)
②治疔疮疖肿:猫爪草45克,煎水头汁分次内服,药渣捣绒,加小金片8片,明矾0.5克,研细拌匀,分2次外敷患处。[《浙江中医杂志》1989,24(6):275]
③治男子乳房发育:猫爪草、生麦芽各50克。煎水代茶饮,每日1剂。[《浙江中医杂志》1989,24(6):275]
④治恶性淋巴瘤、甲状腺肿瘤和乳腺肿瘤:猫爪草、蛇莓、牡蛎各30克,夏枯草9克。水煎服,日1剂。(《抗癌本草》)
夏枯草:
【性味归经】性寒,味辛、苦。归肝经、胆经。
【功效与作用】清火、明目、散结、消肿。
【临床应用】用量9~15克;大剂量30克,水煎服。用治目赤肿痛、目珠夜痛、头痛眩晕、瘰疠、瘿瘤、乳痈肿痛、甲状腺肿大、淋巴结结核、乳腺增生、高血压。
【药理研究】具有降压、抗心律失常、抗炎、免疫抑制、降血糖、抗菌、抗病毒、抗细胞毒作用。
橘红:
【性味归经】性温,味辛、苦。归肺经、脾经。
【功效与作用】散寒、化痰、理气、健脾、消食、燥湿、醒酒、消油腻、宽中、解蟹毒。
【临床应用】煎服。用治风寒咳嗽、喉痒痰多、食积伤酒、呕恶痞闷。柚子皮,蒸鸡冠油服,治老年咳嗽气喘(《中药大辞典》)。长期胃痛、气痛等有独特疗效。
【药理研究】镇静,抗微生物。现代医学研究表明,化州橘红除了药用的有效成份柚皮苷(C27H32O14)与野漆树苷之和超过3.5%外,同时蕴含有超过1.7%的“类素互呔”成份。具有散寒、燥湿、利气、消痰的功效和止咳化痰、抗炎、抗病毒、抗癌、抗过敏、镇痛和降血压等药理作用,常用于风寒咳嗽、喉痒痰多、食积伤酒、呕吐痞闷等症状,能降低血胆固醇、减少血栓的形成,改善局部微循环和营养供给,可用于急性、慢性支气管炎、哮喘,防治心脑血管疾病。
【临床配伍】1、橘红治乳痈,未结即散,已结即溃,极痛不可忍者:陈皮(汤浸去白,日干,面炒黄)为末,麝香研,酒调下二钱。(《圣惠方》橘香散)
2、橘红治嘈杂吐水:真橘皮(去白)为末,五更安五分于掌心舐之,即睡。(《怪证奇方》)
3、橘红治风痰麻木:橘红一斤,逆流水五碗,煮烂去滓,再煮至一碗。顿服取吐。不吐加瓜蒂末。(《摘元方》)4、橘红治痰饮为患,或呕吐憨心,或头眩心悸,或中脘不快。或发为寒热,或因食生冷,脾胃不和:半夏(汤洗七次)、橘红各五两,白茯苓三两,甘草(炙)一两半。上细锉,每服四钱,用水一盏,生姜七片,乌梅一个,同煎六分,去滓热服,不拘时候。(《局方》二陈汤)
5、橘红治产后脾气不利,小便不通:橘红为末,每服二钱,空心,温酒下。(《妇人良方》)
6、橘红治途中心痛:橘皮(去白),煎扬饮之,甚良。(《谈野翁试验方》)香附:
【性味归经】性平,味辛、微苦、微甘。归肝经、三焦经。
【功效与作用】行气解郁、调经止痛。
【临床应用】煎汤内服。用治肝胃不和、气郁不舒、胸腹胁肋胀痛、痰饮痞满、月经不调、崩漏带下等。
【药理研究】挥发油及醇提取物对大鼠有显著的镇痛和解热作用。有松弛平滑肌和雌激素样作用,有抗炎、保肝利胆等药理作用。还有有降血糖、降血脂作用;对胃黏膜有保护作用;可促进离体脂肪组织的分解;有抗病原微生物、抗氧化和细胞凋亡作用。
莱菔子,
【性味归经】性平,味辛、甘。归脾经、胃经、肺经。
【功效与作用】下气、祛痰、消食化积。
【临床应用】煎汤内服;或入丸、敦,宜炒用;外用:适量,研末调敷。用于咳嗽痰喘、食积气滞、胸闷腹胀、下痢后重等症。
【药理研究】促进回肠节律性收缩和抑制胃排空。莱菔子水醇提取液,对麻醉动物静脉注射均有缓和而持久的降压作用,其降压作用与利血平比较无明显差异。水煎剂增强胃肠运动。莱菔子素1毫克/毫升浓度抑制葡萄球菌、大肠杆菌,1∶3水浸剂对同心性毛癣菌、许兰氏黄癣菌等6种皮肤真菌有抑制作用。莱菔子体外对细菌外毒素(破伤风、白喉等)有解毒功效。
以上中药的组合应用,协同发挥临床作用,对于预防和治疗乳腺增生性疾病具有非常良好的疗效,比使用单一的药物疗效确切。该方剂于2005年投入临床实验。患者普遍满意,适用于乳腺增生病患者。
本发明还提供了一种如上所述的中药组合物的制备方法,其制备步骤包括:将各组分清洗干净并干燥后,萃取,提取物混合,制成中药制剂。
所述的中药制剂为中药学上所述的任何一种剂型。可以制成胶囊制剂、片剂、冲剂、口服液制剂、软胶囊制剂等。
本发明的技术方案是:该种防治乳腺增生疾病的保健药物,其特征在于有下列药物组成(重量份),蒲公英提取物占1-30,益母草提取物占1-60,按配方取猫爪草提取物和牡蛎、橘核、白芷、山栀子、半枝莲、荔枝核、夏枯草、橘红、香附、莱菔子药物提取物,混合粉碎至80一100目粒度后,制成中药制剂。
所述的中药制剂为中药学上所述的任何一种剂型。可以制成胶囊制剂、片剂、冲剂、口服液制剂、软胶囊制剂等。
以上药物的组合,联合发挥作用,对于防治乳腺增生性疾病具有非常好的疗效,比单一药物疗效好,效果快,不易反复。
该药物于2005年投入临床试验,患者普遍欢迎,现以下病例进行说明:
例1。治疗乳腺囊性增生150例,疗程3个月,结果显效80例,好转92例,无效8例,总有效率95%.
例2,治疗乳腺小叶增生80例,治愈55例,好转22例,无效5例,93.7%.
例3.治疗乳腺纤维瘤120例,显效100例,有效6例,无效14例,总有效率88%.
例4。治疗乳腺增生动物试验,实验选用雌性日本大耳白兔,按乙烯雌酚+黄体酮诱导方法造成动物乳腺增生模型,将动物分成试验组和对照组,每组20只,试验组用本药灌胃,对照组用三苯氧胺+碘化钾平灌胃,间隔24小时给药一次,然后进行行为学检查和病理学检查,结果试验组乳腺部病理损害,具有明确的改善和治疗作用,比对照组作用好,差异非常显著(P<0.01)。
例5.治疗乳腺增生临床实验,乳腺增生病人60例,结果显效40例,有效12例,无效8例,总有效率96.67%。
具体实施方式:
例一:该种防治乳腺增生疾病的保健药物,有下列药物组成(重量份):橘红,猫爪草,夏枯草,香附,莱菔子提取物占10,蒲公英,牡蛎,橘核,白芷,山栀子,半枝莲,荔枝核,益母草提取物占30,按配方橘红组提取物、蒲公英组提取物,混合粉碎至80一100目粒度后,造粒,装胶囊,制成胶囊制剂。本品每粒重500mg,日服3次,每次1粒。
例二:该种防治乳腺增生管疾病的保健药物,有下列药物组成(重量份):蒲公英、牡蛎、橘核、白芷、山栀子、半枝莲、荔枝核、益母草提取物占30,橘红、猫爪草、夏枯草、香附、莱菔子提取物占10物占10,按配方取蒲公英组提取物、橘红组提取物,混合粉碎至80一100目粒度后,造粒,压片,制成片剂制剂。本品每片重500mg,日服3次,每次1片。
例三:该种防治心乳腺增生疾病的保健药物,有下列药物组成(重量份):橘红,猫爪草,夏枯草,香附,莱菔子占15,蒲公英,牡蛎,橘核,白芷,山栀子,半枝莲,荔枝核,益母草提取物占30,按配方取蒲公英组提取物、橘红组提取物,混合粉碎至80一100目粒度后,制成中药冲剂。本品每包重1g,日服2次,每次1包。
例四:该种防治乳腺增生疾病的保健药物,有下列药物组成(重量份):橘红,猫爪草,夏枯草,香附,莱菔子提取物占20,蒲公英,牡蛎,橘核,白芷,山栀子,半枝莲,荔枝核,益母草40,按配方取蒲公英组提取物、橘红组提取物,混合粉碎至80一100目粒度后,用无菌水溶解,装瓶,制成口服液制剂。
例五:该种防治乳腺增生疾病的保健药物,有下列药物组成(重量份):橘红,猫爪草,夏枯草,香附,莱菔子提取物占10,蒲公英,牡蛎,橘核,白芷,山栀子,半枝莲,荔枝核,益母草20,按配方取蒲公英组提取物、橘红组提取物,混合粉碎至80一100目粒度后,用无菌水溶解,装瓶,制成口服液制剂。本品每瓶10ml,日服1次,每次1瓶。
Claims (7)
1.一种治疗和预防乳腺增生性疾病的纯天然中药方剂,其特征在于有下述重量配比的中药组成:蒲公英5-30g,牡蛎5-30g,橘核5-30g,白芷5-30g,山栀子5-30g,半枝莲5-30g,荔枝核5-30g,益母草5-30g,猫爪草5-30g,夏枯草5-30g,橘红5-30g,香附5-30g,莱菔子5-30g,水煎浓缩提取物混合粉碎至100-200目粒度后,制成中药制剂。
2.根据权利要求1所述的一种治疗和预防乳腺增生性疾病的纯天然中药方剂,其特征在于所述的中药制剂为中药学上所述的任何一种剂型。
3.根据权利要求2所述的一种治疗和预防乳腺增生性疾病的纯天然中药方剂,其特征在于所述的中药制剂为胶囊制剂。
4.根据权利要求2所述的一种治疗和预防乳腺增生性疾病的纯天然中药方剂,其特征在于所述的中药制剂为颗粒冲剂。
5.根据权利要求2所述的一种治疗和预防乳腺增生性疾病的纯天然中药方剂,其特征在于所述的中药制剂为片剂。
6.根据权利要求2所述的一种治疗和预防乳腺增生性疾病的纯天然中药方剂,其特征在于所述的中药制剂为口服液制剂。
7.根据权利要求2所述的一种治疗和预防乳腺增生性疾病的纯天然中药方剂,其特征在于所述的中药制剂为软胶囊制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910977244.8A CN110613784A (zh) | 2019-09-30 | 2019-09-30 | 一种预防和治疗乳腺增生性疾病的纯天然中药方剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910977244.8A CN110613784A (zh) | 2019-09-30 | 2019-09-30 | 一种预防和治疗乳腺增生性疾病的纯天然中药方剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110613784A true CN110613784A (zh) | 2019-12-27 |
Family
ID=68925852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910977244.8A Pending CN110613784A (zh) | 2019-09-30 | 2019-09-30 | 一种预防和治疗乳腺增生性疾病的纯天然中药方剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110613784A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107115447A (zh) * | 2017-05-06 | 2017-09-01 | 孔德兴 | 一种治疗乳腺增生的药物 |
-
2019
- 2019-09-30 CN CN201910977244.8A patent/CN110613784A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107115447A (zh) * | 2017-05-06 | 2017-09-01 | 孔德兴 | 一种治疗乳腺增生的药物 |
Non-Patent Citations (2)
Title |
---|
张丽丹等: "夏枯草的药理研究与临床应用", 《海峡药学》 * |
陈军霞等: "蒲公英药对在妇科疾病治疗方面的研究进展", 《黑龙江中医药》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN101569739B (zh) | 一种治疗胆囊炎的中药组合物及其制备方法 | |
CN104958607A (zh) | 一种治疗妇女更年期灼口综合征的中药组合物及方法 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN105535577A (zh) | 减轻肿瘤病人化疗副反应的药物 | |
CN105535495A (zh) | 一种培元固本治疗食管癌的中药组合物及制备方法 | |
CN102178866B (zh) | 用于气郁、血瘀体质人袪湿活血、软坚散结的中药制剂及其制备方法和应用 | |
CN103212030B (zh) | 一种治疗肝郁型乳腺增生的中药及制备方法 | |
CN110613784A (zh) | 一种预防和治疗乳腺增生性疾病的纯天然中药方剂 | |
CN104338052A (zh) | 治疗脑血栓的中药配方 | |
CN104435641A (zh) | 治疗甲状腺功能亢进症的中药制剂 | |
CN114712466B (zh) | 一种具有减肥养颜功效的药物及其制备方法 | |
CN105998781A (zh) | 一种治疗急性胃肠炎的药物组合物 | |
CN106109895A (zh) | 一种治疗肝郁痰火型慢性咽炎的中药组合物及方法 | |
CN105194577A (zh) | 一种治疗乳腺增生的药剂 | |
CN105477336A (zh) | 抗化疗副反应的健脾和胃制剂膏剂 | |
CN114869987A (zh) | 一种用于预防和治疗肝癌的中药组合物 | |
CN111729053A (zh) | 疏肝和胃的中药组合物、胃特安丸以及制备方法 | |
CN101698088B (zh) | 治疗人体组织增生的中药 | |
CN102138996B (zh) | 一种蜜柚皮加工粉 | |
CN105943839A (zh) | 治疗肝郁痰热型慢性咽炎的中药制备方法及其组合物 | |
CN105535645A (zh) | 胰腺癌患者放疗期间服用的中药组合物及制法 | |
CN105031361A (zh) | 一种医治风火牙痛的制剂及制法 | |
CN105521182A (zh) | 一种医治胰腺癌的制剂及制备方法 | |
CN105012788A (zh) | 一种治疗宫颈癌的方剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20191227 |
|
WD01 | Invention patent application deemed withdrawn after publication |